PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
![Foto de PABLO LUIS](/img/nophoto.png)
![Foto de University of Washington](/img/noimage_org.png)
University of Washington
Seattle, Estados UnidosPublications in collaboration with researchers from University of Washington (1)
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204